Nations Financial Group Inc. IA ADV Buys 2,665 Shares of Cencora, Inc. $COR

Nations Financial Group Inc. IA ADV lifted its stake in Cencora, Inc. (NYSE:COR) by 16.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,692 shares of the company’s stock after purchasing an additional 2,665 shares during the period. Nations Financial Group Inc. IA ADV’s holdings in Cencora were worth $6,313,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in COR. Vanguard Group Inc. grew its holdings in Cencora by 4.1% during the 3rd quarter. Vanguard Group Inc. now owns 23,395,547 shares of the company’s stock worth $7,311,810,000 after acquiring an additional 916,506 shares in the last quarter. State Street Corp grew its holdings in Cencora by 9.3% during the 3rd quarter. State Street Corp now owns 9,190,316 shares of the company’s stock worth $2,872,249,000 after acquiring an additional 782,911 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Cencora by 21.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,677,797 shares of the company’s stock worth $1,461,965,000 after acquiring an additional 821,098 shares in the last quarter. Boston Partners grew its holdings in Cencora by 2.0% during the 3rd quarter. Boston Partners now owns 4,509,165 shares of the company’s stock worth $1,409,152,000 after acquiring an additional 89,506 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in Cencora by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,971,121 shares of the company’s stock worth $1,241,094,000 after acquiring an additional 115,278 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on COR shares. Jefferies Financial Group upgraded shares of Cencora from an “underperform” rating to a “buy” rating in a report on Thursday, January 22nd. Leerink Partners reiterated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Wells Fargo & Company increased their target price on shares of Cencora from $405.00 to $429.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Robert W. Baird set a $415.00 target price on shares of Cencora in a report on Tuesday, January 13th. Finally, JPMorgan Chase & Co. increased their target price on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Twelve equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $398.17.

Insider Activity at Cencora

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the sale, the chief executive officer directly owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.38% of the company’s stock.

Cencora Stock Performance

COR stock opened at $317.22 on Thursday. The firm has a market cap of $61.71 billion, a price-to-earnings ratio of 38.13, a PEG ratio of 1.49 and a beta of 0.72. The firm has a 50-day simple moving average of $343.36 and a two-hundred day simple moving average of $342.88. Cencora, Inc. has a one year low of $271.00 and a one year high of $377.54. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, beating the consensus estimate of $4.04 by $0.04. The business had revenue of $85.93 billion during the quarter, compared to analyst estimates of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $3.73 earnings per share. On average, equities analysts forecast that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s dividend payout ratio is presently 28.85%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.